Key Medicine Shortages – April 2023
Monthly Update
-
Accrete D3 One a Day® 1000mg/880 units chewable tablets - there is a current shortage of this product, with an estimated resolution date of end of May 2023.
Please refer to the memo on StaffNet for information on indications and alternative agents.
-
Oxycodone 5mg/5ml oral solution – Wockhardt is out of stock of oxycodone 5mg/5ml oral solution until end of June 2023. Oxycodone 5mg/5ml oral solution from other manufacturers remains available but will not be able to support increased demand.
Please refer to the memo on StaffNet for advice and actions for primary and secondary care and additional information.
-
Ozempic® (semaglutide) - All strengths of Ozempic® continue to be subject to supply disruptions, which are now anticipated not to be resolved until January 2024.
Please refer to the memo on StaffNet for further information.
Why do medicine shortages occur?
Medicine shortages occur for a variety of reasons, including difficulties sourcing raw materials, product recalls for safety reasons, changes to licence holder, and changes to pack sizes.
It is vitally important that medicine shortages are monitored and appropriate actions taken, to minimise impact on patient care.
Where can I find further advice and information on medicine supply problems and shortages?
For the most up-to-date advice and information please refer to Current Medicine Supply Problems and Shortages page on StaffNet.
Published 05/05/2023. Medicines Update blogs are correct at the time of publication.
If you would like to subscribe to Medicines Update or provide feedback on the blogs, email medicines.update@ggc.scot.nhs.uk.
Follow Medicines Update on Twitter @NHSGGCMeds